Dr Elisa Passini (Department of Computer Science, University of Oxford) is the 2017 3Rs Prize winner. Here she discusses her prize-winning research into the development of computer models of human cardiac cells for the prediction of drug-induced cardiotoxicity. These have the potential to replace animal models in pre-clinical trials, as well as providing a more accurate model of human cardiac activity.
Astex Pharmaceuticals , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its pharmaceutical collaborator, Janssen Pharmaceutica N.V. (Janssen), has been granted Breakthrough Therapy Designation by the US FDA for erdafitinib in the treatment of metastatic urothelial cancer.
NovaBiotics Ltd (NovaBiotics), a clinical-stage anti-infectives biotechnology company, announces receipt of Fast Track Designation (FTD) for its cystic fibrosis (CF) therapy, Lynovex®, from the United States Food and Drug Administration (FDA).
The BIA team recently visited the animal research facilities at King’s College London. It was the first time many in the team had visited animal research facilities to see how pre-clinical research looks in practice.
Today, the Business Secretary Greg Clark has announced that the government is investing over £300 million from its Industrial Strategy Challenge Fund (ISCF) to bring together the UK’s world-class research expertise with business investment to develop technologies and industries that can help the UK prepare for the challenge of an ageing society. £210 million will be invested in the ‘data to early diagnosis and precision medicine’ challenge which will see the UK lead the world in the development of innovative new diagnostic tools, medical products and treatments.
The new and improved BIA website isn’t just sleeker and more user-friendly, it also comes with lots of new functions to help BIA member companies to raise their profile more effectively. One such functionality is the ability for members to upload their news and job vacancies directly to the website, for the BIA team to approve and publish.
Last week, the BIA was all set to head North for the annual Scottish Life Sciences Awards Dinner and a lunch meeting with our members when the Beast from the East hit and all flights were grounded. So sadly, I didn’t get the opportunity to speak to our members about the Scottish Lobbying Act and how it could affect them. Instead, I’ve explained it all here so if you’re not too snowed under with work, do read on…